Source:http://linkedlifedata.com/resource/pubmed/id/16313973
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2006-1-31
|
pubmed:abstractText |
Cancer vaccines using dendritic cells (DCs) have been shown to induce antitumor immunity and have recently been applied to non-immunogenic cancers, such as pancreatic cancer. In this study, we utilized DCs loaded with heat-treated tumor lysate (HTL-DC) as a vaccine in order to stimulate antitumor immunity in a murine pancreatic cancer model and compared them to DCs loaded with tumor lysate (TL-DC). The poorly immunogenic mouse ductal pancreatic cancer cell line PANC02 with syngeneic mouse strain C57BL/6 was used as a model. Inducible heat shock proteins (HSPs) were significantly increased in HTL (HSP70 and HSP90). Tumor size measurements indicated that HTL-DC induced stronger tumor suppression than unpulsed DC or TL-DC (43% reduction in tumor volume compared to control group). T cell proliferation assay and IFN-gamma ELISPOT assay showed that T cell activation increased in the following order: DC<TL-DC<HTL-DC. Furthermore, repeated HTL-DC vaccinations led to higher expansion of IFN-gamma-secreting T cells. Cytotoxicity assay revealed that HTL-DC were more efficient in priming PANC02-specific T cells. Our study identifies HTL as an effective source of tumor-associated antigens (TAAs) for pulsing DCs, and demonstrates that HTL-DC can generate a stronger and broader T cell response against fatal cancers, such as pancreatic cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0165-2478
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
103
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
142-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16313973-Animals,
pubmed-meshheading:16313973-Cell Proliferation,
pubmed-meshheading:16313973-Dendritic Cells,
pubmed-meshheading:16313973-Female,
pubmed-meshheading:16313973-Heat-Shock Proteins,
pubmed-meshheading:16313973-Immunotherapy,
pubmed-meshheading:16313973-Interferon-gamma,
pubmed-meshheading:16313973-Mice,
pubmed-meshheading:16313973-Mice, Inbred C57BL,
pubmed-meshheading:16313973-Pancreatic Neoplasms,
pubmed-meshheading:16313973-Spleen,
pubmed-meshheading:16313973-T-Lymphocytes,
pubmed-meshheading:16313973-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:16313973-Tissue Extracts
|
pubmed:year |
2006
|
pubmed:articleTitle |
Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer.
|
pubmed:affiliation |
Brain Korea 21 Project of Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|